developer, manufacturer and distributor of pharmaceuticals
Value of prescription drugs; Issues related to Medicare Parts B and D; Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Senate Finance Committees Better Mental Health Care, Lower Cost Drugs and Extenders Act (Discussion Draft); S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act Antibiotics/stewardship; S.1355/H.R.2940, PASTEUR Act of 2023; Value of prescription drugs; Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to S. 1844, Animal Drug and Animal Generic Drug User Fee Amendments of 2023; Issues related to HPV vaccine and ACIP recommendations; Expiring healthcare extenders; S. 1339, The Pharmacy Benefit Manager Reform Act
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
TRACY SPICER TRACY SPICER